01/ 04
Connect evidence
Connect production conditions and reagent context with batch and sample identities.
01
← All modalities
AAV · LENTIVIRAL
Gene therapies and viral vectors
Keep the cell system, seed train, transfection or infection, bioreactor records, harvest and purification together. Evaluate vector yield alongside the quality measurements and process context needed to interpret it.
AAV · LentiviralGene therapies and viral vectors
OUTCOMES TRACKEDVector yieldpuritypotency
MODALITY-SPECIFIC PROCESS INTELLIGENCE
Connect vector production with analytical quality.
01Cell system
02Transfection
03Harvest
04Purification
FOCUS AREA · Cell system
Production context
Connect cell-line and seed-train information with reagent and transfection or infection conditions.
01
EVIDENCE · MODELS · DECISIONS
Keep every conclusion connected.
Evidence in Bio Hub
- Cell line, seed train and reagent context
- Transfection, infection and reactor records
- Vector yield, full/empty, purity and potency assays
Models in Bio Twin
- Production and process sensitivity
- Harvest and purification comparisons
- Scale-up scenario assessment
Scientific decisions
- Compare transfection and harvest conditions
- Investigate yield-quality trade-offs
- Evaluate transfer readiness
Process outcomes to evaluate: Vector yield · purity · potency
EXAMPLE INVESTIGATION
Did a higher vector yield preserve the required quality profile?
02/ 04
Compare context
Compare harvest timing and vector measurements across the selected cohorts.
02
03/ 04
Evaluate explanations
Review full/empty, purity and potency-related assays alongside purification recovery.
03
04/ 04
Review next steps
Prepare the yield-quality comparison and propose the evidence needed to resolve remaining uncertainty.
04
Bio Agents can coordinate the scientific work across evidence and models, while Bio OS preserves governance and human review. The configured workflow determines which tasks and models are available.
Bring us this process challenge ↗EVALUATION & SCOPE
Make the demonstration specific.
Vector type, analytical method, host and process stage determine the scope of a comparison. Demonstrated support for one vector workflow should not be assumed to apply unchanged to every vector platform.
What evidence should we bring?
Cell line, seed train and reagent context. Transfection, infection and reactor records. Vector yield, full/empty, purity and potency assays. Include the process question, relevant run context and the analytical methods used to assess the outcome.
How do models support the workflow?
Production and process sensitivity. Harvest and purification comparisons. Scale-up scenario assessment. Scope and evaluation criteria are defined for your process, data and intended decision.
What should we validate before using the results?
Vector type, analytical method, host and process stage determine the scope of a comparison. Demonstrated support for one vector workflow should not be assumed to apply unchanged to every vector platform.
EXPLORE OTHER MODALITIES
ENTERPRISE USE CASE
Reconciling vector yield, recovery and potency across AAV campaigns
A vector-process use case connecting production, fraction recovery, capsid attributes, genome evidence and functional assessment.
Explore the complete use case ↗